Showcasing Early Discovery of Biomarkers Against TREM2 for Alzheimer’s Disease
Time: 4:15 pm
day: Day One
Details:
• Detailing molecular investigations to identify TREM2 pathway-implicated biomarkers in pre-clinical models
• Assessing biomarker use for monitoring efficacy of anti-inflammatory therapies
• Translatable biomarker development efforts to predict and identify neuroinflammation progression in neurodegeneration
